NCT04346459

Brief Summary

This study compares three different supraglottic airway devices used as a conduit for tracheal intubation in order το determine which one achieves the highest success rate of first attempt intubation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 15, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2023

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

3.2 years

First QC Date

April 10, 2020

Last Update Submit

June 30, 2023

Conditions

Keywords

tracheal intubationsupraglottic airway device

Outcome Measures

Primary Outcomes (1)

  • Success rate of intubation at first attempt

    Recording of successful tracheal intubation at first attempt (yes/no) and evaluation of the success rate at first attempt

    Up to study completion, an average of 2 years

Secondary Outcomes (2)

  • Time required for tracheal intubation

    Up to study completion, an average of 2 years

  • Time required for successful supraglottic airway device/ laryngeal mask placement

    Up to study completion, an average of 2 years

Study Arms (3)

Group A- Fastrach (control group)

ACTIVE COMPARATOR

Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using intubating laryngeal mask airway "Fastrach" following blind intubating method through "Fastrach"

Procedure: Tracheal intubation through "Fastrach" - Group A

Group B- I-gel

ACTIVE COMPARATOR

Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using "I-gel" supraglottic airway device as a conduit for tracheal intubation guided by a fiberoptic bronchoscope.

Procedure: Tracheal intubation through "I-gel" - Group B

Group C- Protector

ACTIVE COMPARATOR

Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using the "Protector" laryngeal mask airway as a conduit for tracheal intubation guided by a fiberoptic bronchoscope.

Procedure: Tracheal intubation through "Protector" - Group C

Interventions

Insertion of the intubating laryngeal mask "Fastrach" and blind tracheal intubation through the device

Group A- Fastrach (control group)

Insertion of the supraglottic airway device "i-gel" and tracheal intubation through the device guided by a fiberoptic bronchoscope

Group B- I-gel

Insertion of the laryngeal mask "Protector" and tracheal intubation through the device guided by a fiberoptic bronchoscope

Group C- Protector

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients (age ≥ 18 yrs) scheduled for an elective surgery under general anesthesia
  • Written informed consent to participate in the trial

You may not qualify if:

  • Age \< 18 yrs
  • Non- elective (urgent/ emergency) procedures or multi-trauma patients
  • Obstetric population
  • Surgery performed under regional anesthesia
  • Contraindication to LMA insertion
  • Predicted difficulty in LMA insertion (at least one out of four "RODS" criteria)
  • Contraindication to the use of neuromuscular blockade or situations that require spontaneous breathing
  • Indication for awake intubation or surgical airway
  • Patients' involvement in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Patras

Pátrai, Achaia, 26500, Greece

Location

Study Officials

  • Gregorios Voyagis, MD, PhD

    University of Patras, Department of Anesthesiology and Critical Care

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 10, 2020

First Posted

April 15, 2020

Study Start

January 10, 2020

Primary Completion

March 23, 2023

Study Completion

March 23, 2023

Last Updated

July 3, 2023

Record last verified: 2023-06

Locations